Jacobs School of Medicine and Biomedical Sciences leaders are playing key roles in safely, efficiently and equitably getting Western New York residents vaccinated against COVID-19 through an initiative called Vaccinate Western New York (VAXWNY).
The Lighthouse Free Medical Clinic (LFMC) conducted a virtual auction fundraiser in early February to help it meet the challenges presented by the COVID-19 pandemic and to expand care for underserved communities.
The Department of Surgery has launched an anti-racism and health care equity initiative to address and mitigate the effects of systemic racism and inequality in health care.
Researchers in the Department of Microbiology and Immunology have developed a new, statistically more powerful method that can more effectively detect key functional pathways in cancer using genomics data generated by next-generation sequencing technology.
Students and laboratories affiliated with the Genetics, Genomics and Bioinformatics graduate program (GGB) shared their findings during the seventh annual GGB Research Day.
Research by Gabriela K. Popescu, PhD, professor of biochemistry, has revealed that the absence of a single interaction within a brain receptor reduces its activity. The discovery advances the understanding of how certain brain diseases arise, and could lead to developing precision medicines for treating them.
Medical students at the Jacobs School of Medicine and Biomedical Sciences are finding themselves at the forefront of a new type of medical training brought on by the COVID-19 pandemic.
The University at Buffalo has donated more than 200 reusable 3D-printed face masks and 100 face shields to the Buffalo City Mission for distribution to its clients and staff.
Front-line health care workers, including Jacobs School of Medicine and Biomedical Sciences faculty and medical residents, have begun receiving their COVID-19 vaccines, with some already receiving their second dose.
The first meeting of University at Buffalo’s Cancer Research Consortium was conducted virtually Dec. 10, where it was reported that faculty are working on 97 active cancer research awards totaling $7.4 million in annual direct funding.
Thomas D. Grant, PhD, assistant professor of structural biology, is co-principal investigator on a grant from the National Science Foundation (NSF) to study how small molecules bind to the SARS-COV-2 protease to understand drug binding and help aid drug design.
Memory loss associated with Alzheimer’s disease may be able to be treated by inhibiting certain enzymes involved in abnormal gene transcription, according to a preclinical study led by senior author Zhen Yan, PhD.
At the start of the pandemic, research teams around the world began conducting studies to help further research related to vaccines for the SARS-CoV-2 coronavirus. A team led by Jonathan F. Lovell, PhD, was one of them.
Joseph Terrell Smith Jr., PhD, postdoctoral fellow in microbiology and immunology, has been awarded a three-year, $202,000 F32 grant from the National Institute of Allergy and Infectious Diseases to study the regulation of RNA in Trypanosoma brucei.
Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a computational approach to make drug discovery faster and less expensive while also being safe and effective.
A Phase 2 research study led by Teresa Quattrin, MD, UB Distinguished Professor of pediatrics and senior associate dean for research integration, shows that the drug golimumab preserves beta-cell function in children and young adults with newly-diagnosed Type 1 diabetes for at least a year after diagnosis.
